Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Predicting level 2 axillary lymph node metastasis in a Chinese breast cancer population post-neoadjuvant chemotherapy: development and assessment of a new predictive nomogram.

Liu C, Jiang Y, Gu X, Xu Z, Ai L, Zhang H, Chen G, Sun L, Li Y, Xu H, Gu H, Yu Y, Xu Y, Guo Q.

Oncotarget. 2017 Mar 15;8(45):79147-79156. doi: 10.18632/oncotarget.16131. eCollection 2017 Oct 3.

2.

Nomogram for prediction of level 2 axillary lymph node metastasis in proven level 1 node-positive breast cancer patients.

Jiang Y, Xu H, Zhang H, Ou X, Xu Z, Ai L, Sun L, Liu C.

Oncotarget. 2017 Aug 22;8(42):72389-72399. doi: 10.18632/oncotarget.20395. eCollection 2017 Sep 22.

3.

Sentinel Lymph Node Biopsy in Breast Cancer: A Clinical Review and Update.

Zahoor S, Haji A, Battoo A, Qurieshi M, Mir W, Shah M.

J Breast Cancer. 2017 Sep;20(3):217-227. doi: 10.4048/jbc.2017.20.3.217. Epub 2017 Sep 22. Review.

4.

Identification of sentinel lymph nodes by contrast-enhanced ultrasonography with Sonazoid in patients with breast cancer: a feasibility study in three hospitals.

Shimazu K, Ito T, Uji K, Miyake T, Aono T, Motomura K, Naoi Y, Shimomura A, Shimoda M, Kagara N, Kim SJ, Noguchi S.

Cancer Med. 2017 Aug;6(8):1915-1922. doi: 10.1002/cam4.1142. Epub 2017 Aug 1.

5.

Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08).

van Roozendaal LM, Vane MLG, van Dalen T, van der Hage JA, Strobbe LJA, Boersma LJ, Linn SC, Lobbes MBI, Poortmans PMP, Tjan-Heijnen VCG, Van de Vijver KKBT, de Vries J, Westenberg AH, Kessels AGH, de Wilt JHW, Smidt ML.

BMC Cancer. 2017 Jul 1;17(1):459. doi: 10.1186/s12885-017-3443-x.

6.

Indocyanine green detects sentinel lymph nodes in early breast cancer.

Liu J, Huang L, Wang N, Chen P.

J Int Med Res. 2017 Apr;45(2):514-524. doi: 10.1177/0300060516687149. Epub 2017 Jan 1.

7.

Efficacy of Methylene Blue in Sentinel Lymph Node Biopsy for Early Breast Cancer.

Özdemir A, Mayir B, Demirbakan K, Oygür N.

J Breast Health. 2014 Apr 1;10(2):88-91. doi: 10.5152/tjbh.2014.1914. eCollection 2014 Apr.

8.
9.

Successful Completion of the Pilot Phase of a Randomized Controlled Trial Comparing Sentinel Lymph Node Biopsy to No Further Axillary Staging in Patients with Clinical T1-T2 N0 Breast Cancer and Normal Axillary Ultrasound.

Cyr AE, Tucker N, Ademuyiwa F, Margenthaler JA, Aft RL, Eberlein TJ, Appleton CM, Zoberi I, Thomas MA, Gao F, Gillanders WE.

J Am Coll Surg. 2016 Aug;223(2):399-407. doi: 10.1016/j.jamcollsurg.2016.04.048. Epub 2016 May 20.

10.

The clinical manifestations and treatment of male breast cancer: a report of three cases.

Suehiro S, Abe M, Takumi Y, Hashimoto T, Kamei M, Osoegawa A, Miyawaki M, Sugio K.

Surg Case Rep. 2015 Dec;1(1):92. doi: 10.1186/s40792-015-0103-8. Epub 2015 Oct 5.

11.

A nomogram to predict the probability of axillary lymph node metastasis in early breast cancer patients with positive axillary ultrasound.

Qiu SQ, Zeng HC, Zhang F, Chen C, Huang WH, Pleijhuis RG, Wu JD, van Dam GM, Zhang GJ.

Sci Rep. 2016 Feb 15;6:21196. doi: 10.1038/srep21196.

12.

Axillary Ultrasound Accurately Excludes Clinically Significant Lymph Node Disease in Patients With Early Stage Breast Cancer.

Tucker NS, Cyr AE, Ademuyiwa FO, Tabchy A, George K, Sharma PK, Jin LX, Sanati S, Aft R, Gao F, Margenthaler JA, Gillanders WE.

Ann Surg. 2016 Dec;264(6):1098-1102.

PMID:
26779976
13.

Contrast-Enhanced Color Doppler Ultrasonography for Preoperative Evaluation of Sentinel Lymph Node in Breast Cancer Patients.

Dellaportas D, Koureas A, Contis J, Lykoudis PM, Vraka I, Psychogios D, Kondi-Pafiti A, Voros DK.

Breast Care (Basel). 2015 Oct;10(5):331-5. doi: 10.1159/000436958. Epub 2015 Jul 10.

14.

Sentinel Lymph Node Detection Using Carbon Nanoparticles in Patients with Early Breast Cancer.

Wu X, Lin Q, Chen G, Lu J, Zeng Y, Chen X, Yan J.

PLoS One. 2015 Aug 21;10(8):e0135714. doi: 10.1371/journal.pone.0135714. eCollection 2015.

15.

The role of MRI in axillary lymph node imaging in breast cancer patients: a systematic review.

Kuijs VJ, Moossdorff M, Schipper RJ, Beets-Tan RG, Heuts EM, Keymeulen KB, Smidt ML, Lobbes MB.

Insights Imaging. 2015 Apr;6(2):203-15. doi: 10.1007/s13244-015-0404-2. Epub 2015 Mar 24.

16.

Diagnostic accuracy of sentinel node identification is maintained with the addition of local lidocaine and subareolar radioactive colloid injection.

Stearns V, Blackford A, Kessler J, Sbaity E, Habibi M, Khouri N, Lee CS, May E, Jeter S, Sahebi C, Shehata C, Tarpinian K, Jacobs L, Eisner D.

Breast Cancer Res Treat. 2015 Apr;150(3):589-95. doi: 10.1007/s10549-015-3330-6. Epub 2015 Mar 20.

17.

ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy.

Li JW, Mo M, Yu KD, Chen CM, Hu Z, Hou YF, Di GH, Wu J, Shen ZZ, Shao ZM, Liu GY.

PLoS One. 2014 Dec 11;9(12):e114646. doi: 10.1371/journal.pone.0114646. eCollection 2014.

18.

Axillary reverse mapping: five-year experience.

Ochoa D, Korourian S, Boneti C, Adkins L, Badgwell B, Klimberg VS.

Surgery. 2014 Nov;156(5):1261-8. doi: 10.1016/j.surg.2014.05.011. Epub 2014 Oct 17.

19.

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.

Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, Cataliotti L, Westenberg AH, Klinkenbijl JH, Orzalesi L, Bouma WH, van der Mijle HC, Nieuwenhuijzen GA, Veltkamp SC, Slaets L, Duez NJ, de Graaf PW, van Dalen T, Marinelli A, Rijna H, Snoj M, Bundred NJ, Merkus JW, Belkacemi Y, Petignat P, Schinagl DA, Coens C, Messina CG, Bogaerts J, Rutgers EJ.

Lancet Oncol. 2014 Nov;15(12):1303-10. doi: 10.1016/S1470-2045(14)70460-7. Epub 2014 Oct 15.

20.

Recent progress in the treatment and prevention of cancer-related lymphedema.

Shaitelman SF, Cromwell KD, Rasmussen JC, Stout NL, Armer JM, Lasinski BB, Cormier JN.

CA Cancer J Clin. 2015 Jan-Feb;65(1):55-81. doi: 10.3322/caac.21253. Epub 2014 Nov 19. Review. Erratum in: CA Cancer J Clin. 2015 May-Jun;65(3):252.

Supplemental Content

Support Center